Delay in the clinical diagnosis of breast cancer: Estimating its effect on prognosis, with particular reference to medical litigation

Breast

Volumn 11, Issue 5, 2002, Pages 386-393

  Langlands, A O ^a   Gebski, V ^a   Hirsch, D ^b   Tattersall, M H N ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR;

AUSTRALIA; AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST EXAMINATION; CANCER CLASSIFICATION; CANCER GRADING; CANCER SURVIVAL; DISEASE COURSE; EVIDENCE BASED MEDICINE; HUMAN; LAW SUIT; LYMPH NODE METASTASIS; MALPRACTICE; MAMMOGRAPHY; MEDICAL DECISION MAKING; MEDICOLEGAL ASPECT; PALPATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0036817689     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1054/brst.2002.0456     Document Type: Review

References (42)

1. Keaney M. The delayed diagnosis of breast cancer. Med J Aust 1997; 168: 165-167.
2. Langlands AO. Breast cancer and malpractice litigation. Med J Aust 1998; 169: 212-214.
3. Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 1894; 20: 497-555.
4. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359-377.
5. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade. Histopathology 1991; 19: 403-410.
6. Fisher B. Laboratory and clinical research in breast cancer. Cancer Res 1980: 40: 3863-3874.
7. Langlands AO, Kerr GR. Prognosis in breast cancer; the relevance of clinical staging. Clin Radiol 1978; 29: 599-606.
8. Nemoto T, Vana J, Baker HW et al. Management and survival of female breast cancer; results of a national survey by the American College of Surgeons. Cancer 1980; 45: 2917-2924.
9. Fisher B, Slack NH, Biass ID. Cancer of the breast; size of neoplasm and prognosis. Cancer 1969; 24: 1071-1080.
10. McGuire WL, Tandon AK, Allred DC et al. Treatment decisions in axillary node-negative breast cancer patients. J Natl Cancer Inst 1992; 11: 173-180.
11. Carter CL, Allen C, Henson D. Relation of tumour size, lymph node status and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-187.
12. Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907; 46: 1-19.
13. Koscielny S, Tubiana M, Le MG. et al. Breast cancer; relationship between size of the primary tumour and probability of metastatic dissemination. Br J Cancer 1984; 49: 709-715.
14. Mueller CB. Stage II breast cancer is not simply a late stage I. Surgery 1988; 104: 631-638.
15. Langlands AO, Kerr GR. Prognosis in breast cancer; the effect of age and menstrual status. Clin Oncol 1979; 5: 123-133.
16. Schwartz GF, Zeok JV. Carcinoma of the breast in young women. Am J Surg 1976; 131: 570-574.
17. Gogas J, Skalkeas J. Prognosis of mammary carcinoma in young women. Surgery 1975; 78: 339-342.
18. Ribeiro GG, Swindell R. The prognosis of breast carcinoma in women aged less than 40 years. Clin Radiol 1981; 32: 231-236.
19. Walker RA, Lees E, Webb MB et al. Breast carcinomas occurring in young women (<35 years) are different. Br J Cancer 1996; 74: 1796-1800.
20. Berndt H and Titze U. TNM clinical stage classification of breast cancer. Int J Cancer 1969; 4: 837-844.
21. Fallenius AG, Askensten UG, Skogg LK et al. The reliability of microspectrophometric and flow cytometric nuclear DNA measurements in adenocarcinomas of the breast. Cytometry 1987; 8: 260-266.
22. Haybittle JL, Blamey RW, Elston CW et al. A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361-366.
23. Fisher B, Redmond C, Fisher ER et al. Relative worth of oestrogen or progesterone receptor and pathologic characteristics of differentiation on prognosis in node-negative breast cancer patients; findings from NSABP project protocol B-06. J Clin Oncol 1988; 6: 1076-1087.
24. Robertson JFR. Oestrogen receptor; a stable phenotype in breast cancer. Br J Cancer 1996; 73: 5-12.
25. Lampejo OT, Barnes DM, Smith P et al. Evaluation of infiltrating carcinomas, with a DCIS component; correlation of the histological type of the in situ component with grade of the infiltrating component. Semin Diag Pathol 1994; 11: 215-222.
26. Gupta SK, Douglas-Jones AG, Fenn N et al. The clinical behaviour of breast carcinoma is probably determined at the pre-invasive stage (ductal carcinoma in situ). Cancer 1997; 80: 1740-1745.
27. Millis RR, Barnes DM, Lampejo OT et al. Tumour grade does not change between primary and recurrent mammary carcinoma. Eur J Cancer 1998; 34: 548-553.
28. Kerr GR, Langlands AO, Rodger A. The staging of breast cancer; a comparison of four staging systems in a cohort of 3800 patients. Breast 1993; 2: 160-164.
29. Zujewski J, Liu E. The 1998 St. Gallen consensus conference; an assessment. J Natl Cancer Inst 1998; 90: 1587-1589.
30. Du Toit RS, Locker AD, Ellis IO et al. Evaluation of the prognostic value of triple node biopsy in early breast cancer. Br J Surg 1990; 77: 163-167.
31. Galea MH, Blamey RW, Elston C et al. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-219.
32. Early Breast Cancer Trialists' Collaborative Group. Systematic treatment of early breast cancer by hormonal cytotoxic or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 1992; 339: 71-85.
33. Fisher B, Slack NH, Bross IDJ et al. Cancer of the breast; size of neoplasm and prognosis. Cancer 1969; 24: 1071-1081.
34. Balslev I, Axelsson CK, Zedeler K et al. The Nottingham Prognostic Index applied to 9149 patients from the studies of the Danish Breast Cooperative Group (DBCG). Breast Cancer Res Treat 1994; 32: 281-290.
35. Rutqvist LE, Wallgren A, Nilsson B. Is breast cancer a curable disease? A study of 14 731 women with breast cancer from the cancer registry of Norway. Cancer 1984; 53: 1793-1800.
36. Rutqvist LE, Wallgren A. Long term survival of 458 young breast cancer patients. Cancer 1985; 55: 658-665.
37. Kerr GR, Kunkler I, Langlands AO, Rodger A. (In)curability of breast cancer: a 30-year report of a series of 3933 patients. Breast 1998; 7: 90-94.
38. Mueller CB, Jeffries W. Cancer of the breast: its outcome as measured by the rate of dying and causes of death. Ann Surg 1975; 182: 334-340.
39. Koscielny S, Tubiand M, Valleron AJ. A simulation model of the natural history of human breast cancer. Br J Cancer 1985; 52: 515-524.
40. Koscielny S, Le MG, Tubiana M. The natural history of breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br J Cancer 1989; 59: 775-782.
41. Wilks CJ, Seber G. Chance Encounters. A First Course in Data Analysis and Inference. New York: Wiley; 2000.
42. Andrews BT, Bates T. Delay in diagnosis of breast cancer; medicolegal implications. Breast 2000; 9: 223-237.